XBP Global Reports $1.1B FY25 GAAP Net Income Amidst Revenue Declines Post-Acquisition

summarizeSummary

XBP Global reported a $1.1 billion GAAP net income for FY25 due to acquisition accounting, despite significant year-over-year declines in pro forma revenue and EBITDA, while showing strong growth in new contract value in Q4.

check_boxKey Events

• Full Year 2025 GAAP Net Income

  The company reported a GAAP net income of $1.1 billion for the full year 2025, a significant turnaround from a $215.2 million net loss in the prior year, primarily driven by accounting treatment of the Exela Technologies BPA acquisition.

• Full Year 2025 Pro Forma Revenue Decline

  Pro forma revenue for the full year 2025 totaled $879.6 million, representing a 13.6% decrease year-over-year, reflecting challenges in the post-acquisition transition period.

• Full Year 2025 Pro Forma Normalized EBITDA Decrease

  Pro Forma Normalized EBITDA for the full year 2025 was $90.2 million, a 13.7% decrease compared to the prior year, indicating operational headwinds.

• Q4 2025 Revenue and EBITDA Declines

  Fourth quarter 2025 revenue was $207.0 million, down 15.1% year-over-year on a pro forma basis, with Pro Forma Normalized EBITDA decreasing 35.0% to $19.2 million.

auto_awesomeAnalysis

XBP Global Holdings, Inc. reported a complex set of financial results for the full year and fourth quarter of 2025, reflecting a significant transition following the acquisition of Exela Technologies BPA, LLC in July 2025. While the company posted a substantial GAAP net income of $1.1 billion for the full year, this was primarily an accounting effect of the acquisition, not an indicator of operational profitability. Operationally, both reported and pro forma revenues saw double-digit declines year-over-year, and Pro Forma Normalized EBITDA also decreased. However, the company showed positive momentum in new contract value (TCV and ACV) during Q4 2025, suggesting potential for future revenue growth as it works to stabilize and integrate the acquired business.